382 related articles for article (PubMed ID: 32931884)
41. Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198.
LaVallee TM; Burke PA; Swartz GM; Hamel E; Agoston GE; Shah J; Suwandi L; Hanson AD; Fogler WE; Sidor CF; Treston AM
Mol Cancer Ther; 2008 Jun; 7(6):1472-82. PubMed ID: 18566218
[TBL] [Abstract][Full Text] [Related]
42. Discovery of polymethoxyphenyl-pyridines bearing amino side chains as tubulin colchicine-binding site inhibitors.
Li X; Wu H; Feng KW; Xu J; Wu S; Zhou ZZ; Li XF
Bioorg Med Chem; 2022 Nov; 73():117007. PubMed ID: 36150341
[TBL] [Abstract][Full Text] [Related]
43. Structure-based design and synthesis of BML284 derivatives: A novel class of colchicine-site noncovalent tubulin degradation agents.
Zhang C; Yan W; Liu Y; Tang M; Teng Y; Wang F; Hu X; Zhao M; Yang J; Li Y
Eur J Med Chem; 2024 Mar; 268():116265. PubMed ID: 38430854
[TBL] [Abstract][Full Text] [Related]
44. Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
Zhu H; Li W; Shuai W; Liu Y; Yang L; Tan Y; Zheng T; Yao H; Xu J; Zhu Z; Yang DH; Chen ZS; Xu S
Eur J Med Chem; 2021 Apr; 216():113316. PubMed ID: 33676300
[TBL] [Abstract][Full Text] [Related]
45. Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.
Gilson P; Josa-Prado F; Beauvineau C; Naud-Martin D; Vanwonterghem L; Mahuteau-Betzer F; Moreno A; Falson P; Lafanechère L; Frachet V; Coll JL; Fernando Díaz J; Hurbin A; Busser B
Sci Rep; 2017 Aug; 7(1):10209. PubMed ID: 28860487
[TBL] [Abstract][Full Text] [Related]
46. Tubulin inhibitory activity of a novel colchicine-binding compounds based on a dinaphthospiropyranran scaffold.
Sundriyal S; Eeda V; Lagisetty P; Awasthi V
Bioorg Med Chem; 2021 Jan; 29():115874. PubMed ID: 33223461
[TBL] [Abstract][Full Text] [Related]
47. Computational-Based Discovery of the Anti-Cancer Activities of Pyrrole-Based Compounds Targeting the Colchicine-Binding Site of Tubulin.
Boichuk S; Syuzov K; Bikinieva F; Galembikova A; Zykova S; Gankova K; Igidov S; Igidov N
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566235
[TBL] [Abstract][Full Text] [Related]
48. Estradiol dimer inhibits tubulin polymerization and microtubule dynamics.
Jurášek M; Černohorská M; Řehulka J; Spiwok V; Sulimenko T; Dráberová E; Darmostuk M; Gurská S; Frydrych I; Buriánová R; Ruml T; Hajdúch M; Bartůněk P; Dráber P; Džubák P; Drašar PB; Sedlák D
J Steroid Biochem Mol Biol; 2018 Oct; 183():68-79. PubMed ID: 29803726
[TBL] [Abstract][Full Text] [Related]
49. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.
Podolski-Renić A; Banković J; Dinić J; Ríos-Luci C; Fernandes MX; Ortega N; Kovačević-Grujičić N; Martín VS; Padrón JM; Pešić M
Eur J Pharm Sci; 2017 Jul; 105():159-168. PubMed ID: 28502672
[TBL] [Abstract][Full Text] [Related]
50. Identification of Essential 2D and 3D Chemical Features for Discovery of the Novel Tubulin Polymerization Inhibitors.
Azimi F; Ghasemi JB; Saghaei L; Hassanzadeh F; Mahdavi M; Sadeghi-Aliabadi H; Scotti MT; Scotti L
Curr Top Med Chem; 2019; 19(13):1092-1120. PubMed ID: 31109275
[TBL] [Abstract][Full Text] [Related]
51. Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening.
Federico LB; Silva GM; de Fraga Dias A; Figueiró F; Battastini AMO; Dos Santos CBR; Costa LT; Rosa JMC; de Paula da Silva CHT
Int J Biol Macromol; 2020 Dec; 165(Pt B):3040-3050. PubMed ID: 33736292
[TBL] [Abstract][Full Text] [Related]
52. Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
Canela MD; Noppen S; Bueno O; Prota AE; Bargsten K; Sáez-Calvo G; Jimeno ML; Benkheil M; Ribatti D; Velázquez S; Camarasa MJ; Díaz JF; Steinmetz MO; Priego EM; Pérez-Pérez MJ; Liekens S
Oncotarget; 2017 Feb; 8(9):14325-14342. PubMed ID: 27224920
[TBL] [Abstract][Full Text] [Related]
53. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
Bhattacharyya B; Panda D; Gupta S; Banerjee M
Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.
Wang YT; Cai XC; Shi TQ; Zhang YL; Wang ZC; Liu CH; Zhu HL
Chem Biol Drug Des; 2017 Jul; 90(1):112-118. PubMed ID: 28032450
[TBL] [Abstract][Full Text] [Related]
55. Ligand- and structural-based discovery of potential small molecules that target the colchicine site of tubulin for cancer treatment.
Guo Q; Zhang H; Deng Y; Zhai S; Jiang Z; Zhu D; Wang L
Eur J Med Chem; 2020 Jun; 196():112328. PubMed ID: 32320841
[TBL] [Abstract][Full Text] [Related]
56. Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties.
Wu JD; Cui YJ; Zhou YG; Tang LQ; Zhang CM; Liu ZP
Invest New Drugs; 2020 Feb; 38(1):29-38. PubMed ID: 30887253
[TBL] [Abstract][Full Text] [Related]
57. Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity.
Magalhaes LG; Marques FB; da Fonseca MB; Rogério KR; Graebin CS; Andricopulo AD
PLoS One; 2016; 11(8):e0160842. PubMed ID: 27508497
[TBL] [Abstract][Full Text] [Related]
58. Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer.
Deng S; Krutilina RI; Hartman KL; Chen H; Parke DN; Wang R; Mahmud F; Ma D; Lukka PB; Meibohm B; Seagroves TN; Miller DD; Li W
Mol Cancer Ther; 2022 Jul; 21(7):1103-1114. PubMed ID: 35499388
[TBL] [Abstract][Full Text] [Related]
59. Identification of novel and potent small-molecule inhibitors of tubulin with antitumor activities by virtual screening and biological evaluations.
Liu G; Jiao Y; Huang C; Chang P
J Comput Aided Mol Des; 2019 Jul; 33(7):659-664. PubMed ID: 31165955
[TBL] [Abstract][Full Text] [Related]
60. Discovery of Novel
Leng J; Zhao Y; Sheng P; Xia Y; Chen T; Zhao S; Xie S; Yan X; Wang X; Yin Y; Kong L
J Med Chem; 2022 Dec; 65(24):16774-16800. PubMed ID: 36471625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]